Back to results

Test 1605marketcrmcrmmarketv2

Test 1505mTest 1505marketarket
Interest / Relevance: Test 1505market

Reference:

T81228441V

Business Developper
contact
Inserm Transfert
Research Tools
Specificity: Mouse
Rare disease:
Last update: 16/05/2024

You might also be interested in

BIO22037-R1

Cd38 as a biomarker and biotarget in

Lorem ipsum […]

Read more
BIO19413-D1

Methods and compositions for treating cell

The inventors have surprisingly demonstrated that GD3 positive senescent cells inhibit NK cell in […]

Read more
BIO18140-T1

Method for treating t- helper type 2 mediated

The present invention relates to the treatment of T- helper type 2 (Th2)-mediated disease. Here, […]

Read more
BIO16260-T1

Use of antagonists of th17 cytokines for the

Bronchial remodelling is a prominent feature of severe asthma and a potential therapeutic target. […]

Read more
BIO18240-T1

Antibodies specific for il20-rb and uses thereof

Chronic obstructive pulmonary disease (COPD) remains a major cause of morbidity and mortality […]

Read more
BIO19413-T1

Methods and compositions for treating cell

The inventors have surprisingly demonstrated that GD3 positive senescent cells inhibit NK cell in […]

Read more
CHIM19384-T1

Selective pharmacological inhibition of epac1 for

The present invention relates to the treatment of idiopathic pulmonary fibrosis. Today, there is no […]

Read more
BIO17093-D1

Methods for predincting the risk of developing

The present invention relates to methods for predicting the risk of developing pulmonary […]

Read more
BIO17336-T1

Methods and composition for the treatment of

The present invention relates to a method of treating allergic asthma in a subject in need thereof […]

Read more
BIO17093-D2

Methods for predincting the risk of developing

The present invention relates to methods for predicting the risk of developing pulmonary […]

Read more